Search
for
Sort by
Research 151–180 of 405
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- SINDROMA CUSHING PADA KEHAMILAN
- Characterization of spironolactone and metabolites derivatized using Girard's reagent P using mass spectrometry and ion mobility spectrometry
- Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study
- A systematic review of antiandrogens and feminization in transgender women
- Association of Hypertension and Serum Aldosterone Levels in Male Patients with Androgenetic Alopecia: A Case-Control Study
- Corticosterone enhances the potency of ethanol against hippocampal long-term potentiation via local neurosteroid synthesis
- Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar‐I disorder: A double‐blind, randomized, placebo‐controlled clinical trial
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone
- Spironolactone versus Bicalutamide for Female Pattern Hair Loss: A 24-Month Unicenter Retrospective Comparative Study of Effectiveness and Safety
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Effectiveness of short term canrenone treatment in idiopathic hirsutism.
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- Spironolacton in dermatologischen Behandlungen
- Treatment options for polycystic ovary syndrome
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension
- An N-Ethyl-N-Nitrosourea Induced Corticotropin-Releasing Hormone Promoter Mutation Provides a Mouse Model for Endogenous Glucocorticoid Excess
- Endocrine Functions of the Testes
- Dermatologic Changes in Experimental Model of Long COVID
- Interventions for central serous chorioretinopathy: a network meta-analysis
- Sex differences in arterial hypertension
- Recent advances in the role of neuroregulation in skin wound healing
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches